▶ 調査レポート

世界の核医学診断装置市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Nuclear Medicine Diagnostic Equipment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の核医学診断装置市場2023年:企業・地域・種類・用途別分析 / Global Nuclear Medicine Diagnostic Equipment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z7408資料のイメージです。• レポートコード:MRC309Z7408
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の核医学診断装置の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の核医学診断装置市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 核医学診断装置の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

核医学診断装置市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・スペクト、ペット

用途別セグメント
・腫瘍イメージング、骨髄イメージング、内分泌系イメージング、泌尿器系イメージング、その他

主要な市場プレーヤー
・GE HealthCare、Siemens Healthineers、Philips、Mediso Medical Imaging Systems、Digirad、Toshiba、Compañía Mexicana、SurgicEye、CMR Naviscan、DDD-Diagnostic、Positron、TeraRecon、Neusoft Group、United Imaging、MinFound Medical、SinoUnion Healthcare、Top Grade Healthcare

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、核医学診断装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な核医学診断装置メーカーの企業概要、2019年~2022年までの核医学診断装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な核医学診断装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別核医学診断装置の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの核医学診断装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での核医学診断装置市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および核医学診断装置の産業チェーンを掲載しています。
・第14、15章では、核医学診断装置の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 核医学診断装置の概要
- 種類別分析(2018年vs2022年vs2029年):スペクト、ペット
- 用途別分析(2018年vs2022年vs2029年):腫瘍イメージング、骨髄イメージング、内分泌系イメージング、泌尿器系イメージング、その他
- 世界の核医学診断装置市場規模・予測
- 世界の核医学診断装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- GE HealthCare、Siemens Healthineers、Philips、Mediso Medical Imaging Systems、Digirad、Toshiba、Compañía Mexicana、SurgicEye、CMR Naviscan、DDD-Diagnostic、Positron、TeraRecon、Neusoft Group、United Imaging、MinFound Medical、SinoUnion Healthcare、Top Grade Healthcare
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:スペクト、ペット
・用途別分析2018年-2029年:腫瘍イメージング、骨髄イメージング、内分泌系イメージング、泌尿器系イメージング、その他
・核医学診断装置の北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・核医学診断装置のヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・核医学診断装置のアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・核医学診断装置の南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・核医学診断装置の中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Nuclear Medicine Diagnostic Equipment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.

Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.
Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .
This report is a detailed and comprehensive analysis for global Nuclear Medicine Diagnostic Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nuclear Medicine Diagnostic Equipment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Medicine Diagnostic Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Medicine Diagnostic Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Nuclear Medicine Diagnostic Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nuclear Medicine Diagnostic Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Nuclear Medicine Diagnostic Equipment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Siemens Healthineers, Philips, Mediso Medical Imaging Systems and Digirad, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Nuclear Medicine Diagnostic Equipment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
SPECT
PET
Market segment by Application
Tumor Imaging
Bone Marrow Imaging
Endocrine System Imaging
Urinary System Imaging
Others
Major players covered
GE HealthCare
Siemens Healthineers
Philips
Mediso Medical Imaging Systems
Digirad
Toshiba
Compañía Mexicana
SurgicEye
CMR Naviscan
DDD-Diagnostic
Positron
TeraRecon
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Top Grade Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine Diagnostic Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nuclear Medicine Diagnostic Equipment, with price, sales, revenue and global market share of Nuclear Medicine Diagnostic Equipment from 2018 to 2023.
Chapter 3, the Nuclear Medicine Diagnostic Equipment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine Diagnostic Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nuclear Medicine Diagnostic Equipment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Medicine Diagnostic Equipment.
Chapter 14 and 15, to describe Nuclear Medicine Diagnostic Equipment sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Diagnostic Equipment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nuclear Medicine Diagnostic Equipment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 SPECT
1.3.3 PET
1.4 Market Analysis by Application
1.4.1 Overview: Global Nuclear Medicine Diagnostic Equipment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor Imaging
1.4.3 Bone Marrow Imaging
1.4.4 Endocrine System Imaging
1.4.5 Urinary System Imaging
1.4.6 Others
1.5 Global Nuclear Medicine Diagnostic Equipment Market Size & Forecast
1.5.1 Global Nuclear Medicine Diagnostic Equipment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Nuclear Medicine Diagnostic Equipment Sales Quantity (2018-2029)
1.5.3 Global Nuclear Medicine Diagnostic Equipment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GE HealthCare
2.1.1 GE HealthCare Details
2.1.2 GE HealthCare Major Business
2.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Product and Services
2.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GE HealthCare Recent Developments/Updates
2.2 Siemens Healthineers
2.2.1 Siemens Healthineers Details
2.2.2 Siemens Healthineers Major Business
2.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product and Services
2.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Siemens Healthineers Recent Developments/Updates
2.3 Philips
2.3.1 Philips Details
2.3.2 Philips Major Business
2.3.3 Philips Nuclear Medicine Diagnostic Equipment Product and Services
2.3.4 Philips Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Philips Recent Developments/Updates
2.4 Mediso Medical Imaging Systems
2.4.1 Mediso Medical Imaging Systems Details
2.4.2 Mediso Medical Imaging Systems Major Business
2.4.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product and Services
2.4.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mediso Medical Imaging Systems Recent Developments/Updates
2.5 Digirad
2.5.1 Digirad Details
2.5.2 Digirad Major Business
2.5.3 Digirad Nuclear Medicine Diagnostic Equipment Product and Services
2.5.4 Digirad Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Digirad Recent Developments/Updates
2.6 Toshiba
2.6.1 Toshiba Details
2.6.2 Toshiba Major Business
2.6.3 Toshiba Nuclear Medicine Diagnostic Equipment Product and Services
2.6.4 Toshiba Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Toshiba Recent Developments/Updates
2.7 Compañía Mexicana
2.7.1 Compañía Mexicana Details
2.7.2 Compañía Mexicana Major Business
2.7.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product and Services
2.7.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Compañía Mexicana Recent Developments/Updates
2.8 SurgicEye
2.8.1 SurgicEye Details
2.8.2 SurgicEye Major Business
2.8.3 SurgicEye Nuclear Medicine Diagnostic Equipment Product and Services
2.8.4 SurgicEye Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 SurgicEye Recent Developments/Updates
2.9 CMR Naviscan
2.9.1 CMR Naviscan Details
2.9.2 CMR Naviscan Major Business
2.9.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product and Services
2.9.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CMR Naviscan Recent Developments/Updates
2.10 DDD-Diagnostic
2.10.1 DDD-Diagnostic Details
2.10.2 DDD-Diagnostic Major Business
2.10.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product and Services
2.10.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 DDD-Diagnostic Recent Developments/Updates
2.11 Positron
2.11.1 Positron Details
2.11.2 Positron Major Business
2.11.3 Positron Nuclear Medicine Diagnostic Equipment Product and Services
2.11.4 Positron Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Positron Recent Developments/Updates
2.12 TeraRecon
2.12.1 TeraRecon Details
2.12.2 TeraRecon Major Business
2.12.3 TeraRecon Nuclear Medicine Diagnostic Equipment Product and Services
2.12.4 TeraRecon Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TeraRecon Recent Developments/Updates
2.13 Neusoft Group
2.13.1 Neusoft Group Details
2.13.2 Neusoft Group Major Business
2.13.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Product and Services
2.13.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Neusoft Group Recent Developments/Updates
2.14 United Imaging
2.14.1 United Imaging Details
2.14.2 United Imaging Major Business
2.14.3 United Imaging Nuclear Medicine Diagnostic Equipment Product and Services
2.14.4 United Imaging Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 United Imaging Recent Developments/Updates
2.15 MinFound Medical
2.15.1 MinFound Medical Details
2.15.2 MinFound Medical Major Business
2.15.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Product and Services
2.15.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MinFound Medical Recent Developments/Updates
2.16 SinoUnion Healthcare
2.16.1 SinoUnion Healthcare Details
2.16.2 SinoUnion Healthcare Major Business
2.16.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product and Services
2.16.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 SinoUnion Healthcare Recent Developments/Updates
2.17 Top Grade Healthcare
2.17.1 Top Grade Healthcare Details
2.17.2 Top Grade Healthcare Major Business
2.17.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product and Services
2.17.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Top Grade Healthcare Recent Developments/Updates
3 Competitive Environment: Nuclear Medicine Diagnostic Equipment by Manufacturer
3.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Manufacturer (2018-2023)
3.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Nuclear Medicine Diagnostic Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Nuclear Medicine Diagnostic Equipment Manufacturer Market Share in 2022
3.4.2 Top 6 Nuclear Medicine Diagnostic Equipment Manufacturer Market Share in 2022
3.5 Nuclear Medicine Diagnostic Equipment Market: Overall Company Footprint Analysis
3.5.1 Nuclear Medicine Diagnostic Equipment Market: Region Footprint
3.5.2 Nuclear Medicine Diagnostic Equipment Market: Company Product Type Footprint
3.5.3 Nuclear Medicine Diagnostic Equipment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Region
4.1.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Region (2018-2029)
4.1.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Region (2018-2029)
4.1.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Region (2018-2029)
4.2 North America Nuclear Medicine Diagnostic Equipment Consumption Value (2018-2029)
4.3 Europe Nuclear Medicine Diagnostic Equipment Consumption Value (2018-2029)
4.4 Asia-Pacific Nuclear Medicine Diagnostic Equipment Consumption Value (2018-2029)
4.5 South America Nuclear Medicine Diagnostic Equipment Consumption Value (2018-2029)
4.6 Middle East and Africa Nuclear Medicine Diagnostic Equipment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
5.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Type (2018-2029)
5.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
6.2 Global Nuclear Medicine Diagnostic Equipment Consumption Value by Application (2018-2029)
6.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Application (2018-2029)
7 North America
7.1 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
7.2 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
7.3 North America Nuclear Medicine Diagnostic Equipment Market Size by Country
7.3.1 North America Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2018-2029)
7.3.2 North America Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
8.2 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
8.3 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country
8.3.1 Europe Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2018-2029)
8.3.2 Europe Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Nuclear Medicine Diagnostic Equipment Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
10.2 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
10.3 South America Nuclear Medicine Diagnostic Equipment Market Size by Country
10.3.1 South America Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2018-2029)
10.3.2 South America Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Nuclear Medicine Diagnostic Equipment Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Nuclear Medicine Diagnostic Equipment Market Drivers
12.2 Nuclear Medicine Diagnostic Equipment Market Restraints
12.3 Nuclear Medicine Diagnostic Equipment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Nuclear Medicine Diagnostic Equipment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Medicine Diagnostic Equipment
13.3 Nuclear Medicine Diagnostic Equipment Production Process
13.4 Nuclear Medicine Diagnostic Equipment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Medicine Diagnostic Equipment Typical Distributors
14.3 Nuclear Medicine Diagnostic Equipment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer